Progyny, Inc. Marketable Securities (Current)
Progyny, Inc. (PGNY) had Marketable Securities (Current) of $38.99 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:MarketableSecuritiesCurrent · last filed 2021-03-01
- 2020-12-31: Marketable Securities, Current $38.99M.
- 2020-09-30: Marketable Securities, Current $50.99M.
- 2020-06-30: Marketable Securities, Current $41.98M.
| Period end | Marketable Securities, Current |
|---|---|
| 2020-12-31 | $38.99M 10-K · filed 2021-03-01 |
| 2020-09-30 | $50.99M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $41.98M 10-Q · filed 2020-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |